Related Experiment Video
Updated: Jul 19, 2025

06:15
A Surgical Approach for Optic Nerve Crush in a Rabbit Model
Published on: July 8, 2025
255
Veterinary deworming agent-induced toxic optic neuropathy: a case report
1Department of Ophthalmology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510000, China.
BMC Ophthalmology
|August 15, 2023
Summary
Veterinary antiparasitic drugs triclabendazole and bithionol can cause toxic optic neuropathy. Enhanced warnings are needed for these widely used medications to prevent human poisoning.
Area of Science:
- Veterinary medicine
- Toxicology
- Ophthalmology
Background:
- Veterinary antiparasitic drugs are prevalent in endemic regions, posing risks of accidental human ingestion and poisoning.
- Parasitic infections necessitate the use of veterinary drugs, increasing potential human exposure.
Observation:
- A 40-year-old male with cirrhosis presented with progressive vision loss.
- The patient had a history of taking veterinary antiparasitic drugs, specifically triclabendazole and bithionol.
- Examination revealed toxic optic neuropathy, unresponsive to standard treatments like steroids and oxygen therapy.
Findings:
- Triclabendazole and bithionol were identified as potential causes of toxic optic neuropathy.
- The patient's optic neuropathy was directly linked to the ingestion of these veterinary antiparasitic agents.
Implications:
- Triclabendazole and bithionol warrant enhanced regulatory supervision and clear warning labels due to their neurotoxic potential.
- Healthcare providers should be aware of the risks associated with veterinary antiparasitic drugs in cases of human optic neuropathy.
- Further research into the mechanisms of optic neurotoxicity of these drugs is recommended.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
921
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
921
Open Angle Glaucoma: Treatment
479
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
479
Angle Closure Glaucoma: Treatment
560
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
560

